Industry Supported Symposia
Menu
The following industry supported symposia (ISS) are organized by sponsors of the 19th ISDE World Congress for Esophageal Diseases and will be available during the 2023 Live Days.
Educational Industry Supported Symposia
ISS01- Emerging Trends in Eosinophilic Esophagitis
Time: 08 September, 12:30 - 13:30 EDT
Session Details
Presentation Titles
- Why Does EoE Happen?
- Topical Steroids in EoE
- Monoclonal Agents and Newer therapies
Speakers

Nirmala Gonsalves
Northwestern University

David Katzka
Columbia University

Serge Mayrand
McGill University
ISS01 - Immune-Oncology in Esophageal Cancer
Time: 09 September, 12:30 - 13:30 EDT
Session Details
Presentation Titles
- Checkpoint Inhibition for Adenocarcinoma of the Esophagus and EGJ
- Checkpoint Inhibition for Esophageal Squamous Cell Carcinoma
- Immune Checkpoint Inhibition in the Neoadjuvant/Adjuvant Setting
Speakers

Filippo Pietrantonio
Fondazione IRCCS Istituto Nazionale dei Tumori

Ken Kato
National Cancer Center Japan

Dan Catenacci
United States
ISS03 - Towards Effective Therapy in Eosinophilic Esophagitis
Time: 10 September, 12:30 - 13:30 EDT
Session Details
Presentation Titles
- EoE Epidemiology and Natural History – Why So Often Missed?
- Rational Diet Therapy in EoE
- Medical Management of EoE: a Tough Pill to Swallow
Speakers

Nicholas Shaheen
University of North Carolina Chapel Hill

Kathryn Peterson
University of Utah

Joy Chang
University of Michigan Medicine

Description
The presentation is based off of the disease state, clinical presentation, diagnosis and treatment of EoE. It then transitions into a branded presentation on Dupixent.
This talk will be given by Dr. Hirano, MD.